Tag: meeting

Stockholm, 5 August 2025 - Virtune today announces the completion of the monthly rebalancing for the Virtune Crypto Top 10 Index ETP, listed on Nasdaq Stockholm for both the SEK-denominated (ISIN code SE0020052207, ticker name VIR10SEK) and the EUR-denominated (ISIN code SE0020052215, ticker name VIR10EUR) ETP.

In addition to the Virtune Crypto Top 10 Index ETP, Virtune's product portfolio includes:

Virtune Bitcoin ETP
Virtune Stellar ETP
Virtune Staked Ethereum ETP
Virtune Staked Solana ETP
Virtune Staked Polkadot ETP
Virtune XRP ETP
Virtune Avalanche ETP
Virtune Litecoin ETP
Virtune Chainlink ETP
Virtune Arbitrum ETP
Virtune Staked Polygon ETP
Virtune Staked Cardano ETP
Virtune Crypto Altcoin Index ETP
Virtune Bitcoin Prime ETP
Virtune Coinbase 50 Index ETP

Index allocation as of 31st of July (before rebalancing):

Ethereum: 37.10%
Bitcoin: 34.43%
XRP: 14.81%
Solana: 7.56%
Cardano: 2.18%
Stellar: 1.04%
Chainlink: 0.93%
Avalanche: 0.79%
Litecoin: 0.67%
Uniswap: 0.49%

Index allocation as of 31st of July (after rebalancing):

Bitcoin: 40.00%
Ethereum: 31.61%
XRP: 14.72%
Solana: 7.68%
Cardano: 2.20%
Stellar: 1.02%
Chainlink: 0.93%
Avalanche: 0.76%
Litecoin: 0.62%
Uniswap: 0.47%

In connection with this month's rebalancing, there is no change in the crypto assets included in the index. Virtune Crypto Top 10 Index ETP SEK outcome for July was +31.92%

The rebalancing is carried out according to the index that the ETP tracks, the Virtune Crypto Top 10 Index. The purpose of the monthly rebalancing is to ensure that the ETP always reflects the current market conditions and to effectively absorb volatility in the crypto market.

In July, the market showed broad strength, with several major crypto assets ending the month in positive territory. Stellar led with a remarkable gain of +68.7%, followed by Ethereum +48.7%, XRP +35.0%, and Uniswap +31.1%. 

The performance of the crypto assets included in Virtune Crypto Top 10 Index ETP in July:

Stellar: +68,7%
Ethereum: +48.7%
XRP: +35.0%
Uniswap: +31.1%
Cardano: +29.3%
Chainlink: +26.7%
Avalanche: +25.1%
Litecoin: +23.4%
Solana: +11.3%
Bitcoin: +8.02%

Virtune's crypto index ETP is the first of its kind in the Nordic region. The ETP includes up to 10 leading crypto assets and are based on their total market capitalization, with a maximum weight of 40% per crypto asset to promote diversification. This allows investors to benefit from broad exposure to the crypto market without being heavily concentrated in any single crypto asset.

If you, as an (institutional) investor, are interested in meeting with Virtune to discuss the opportunities our ETPs offer for your asset management services or to learn more about Virtune and our ETPs, please do not hesitate to contact us at hello@virtune.com. You can also read more about Virtune and our ETPs at www.virtune.com and register your email address on our website to subscribe to our newsletters, which cover updates on Virtune's upcoming ETP launches and other news related to digital assets.

Press contact
Christopher Kock, CEO Virtune AB (Publ)
Christopher@virtune.com
+46 70 073 45 64

Virtune with its headquarters in Stockholm is a regulated Swedish digital asset manager and issuer of crypto exchange traded products on regulated European exchanges. With regulatory compliance, strategic collaborations with industry leaders and our proficient team, we empower investors on a global level to access innovative and sophisticated investment products that are aligned with the evolving landscape of the global crypto market.

Explore how GLP-1a drugs transform the food industry from a threat to an opportunity. Our 36-page strategy briefing outlines the potential for growth by meeting the rising demand for protein, fiber, and nutrients. Discover insights, identified consumer groups, and actionable strategies for food companies.

/Translation from Lithuanian/

Wuppertal, Germany, August 5, 2025 - Aicuris Anti-infective Cures AG today announced initial clinical data from its ongoing first-in-human Phase 1 trial with AIC468. The novel antiviral antisense oligonucleotide is in development for the treatment of BK virus (BKV) infections in kidney transplant recipients. The interim results, presented at the World Transplant Congress in San Francisco on August 4, 2025, provide an overview of PK characteristics of AIC468 from the Phase 1 clinical trial in healthy volunteers.

LAUNCESTON, Australia, Aug. 05, 2025 (GLOBE NEWSWIRE) -- Onefxclub.info is a financial services firm recognized for offering steady and consistent support to its clients across various sectors. With a clear commitment to accessibility, the company provides 24/7 customer service to ensure every inquiry, request, and need is addressed without delay. Around-the-clock assistance remains a core part of how the organization aims to support financial stability, reduce delays in service resolution, and respond to client expectations with a sense of urgency and availability.

eQ Plc stock exchange release
5 August 2025, at 8:15 a.m.

Press Release